How many insider declarations does 명인제약 have?

명인제약 has filed 4 insider declarations with DART (FSS).

Who is the top reporting insider at 명인제약?

The top reporting insider at 명인제약 is 이행명, based on the count of public filings.

What is the net insider buy vs sell volume on 명인제약?

Across the available history, declared buys total 0 and disposals 0.

InsidersTradesSigma

← Companies ★ Sign in to follow

명인제약: insider trades · South Korea · DART (FSS)

DART:company-b0a9c3KR·DART (FSS)Mcap 1005.9Bn€

AMF ↗

Discover the full insider trade history of 명인제약, a listed equity based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Market capitalisation: €1,005.9bn. The latest transaction was filed on 8 May 2026 (Purchase). Among the most active insiders: 이행명. The full history is openly available.

4

Insider Decl.

0

Thresholds

·

2 ops.

Buy Volume

·

2 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

50800.00 €

Income statement

Revenue287.25 Bn€

Gross profit173.99 Bn€61% margin

Net income81.44 Bn€28.3% margin

Balance sheet & cash

Market cap1005.94 Bn€

Total debt1.39 Bn€

Free Cash Flow46.71 Bn€

Last declaration on 8 May 2026

All Executives4 Thresholds Prospectus Other

Declarations0 total

No declarations found

0 of 0 declarations